Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Microarrays (Basel, Switzerland)
|
September 8, 2016
Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery
Astrid Wachter, Stephan Bernhardt, Tim Beissbarth, et al.
Expert Review of Proteomics
|
November 18, 2014
Subtyping of breast cancer using reverse phase protein arrays
Johanna Sonntag, Kerstin Schlüter, Stephan Bernhardt, et al.
Future Oncology (London, England)
|
March 16, 2021
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry
Arne Strauss, Marianne Schmid, Michael Rink, et al.
Future Oncology (London, England)
|
October 6, 2020
Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry
Martin Boegemann, Katrin Schlack, Michael Rink, et al.
Journal of Proteome Research
|
January 5, 2019
Functional Proteomics of Breast Cancer Metabolism Identifies GLUL as Responder during Hypoxic Adaptation
Stephan Bernhardt, Christian Tönsing, Devina Mitra, et al.
International Journal of Molecular Sciences
|
November 1, 2014
Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization
Matthias Bache, Stephan Bernhardt, Sarina Passin, et al.
Scientific Reports
|
February 16, 2016
Mechanisms and consequences of ATMIN repression in hypoxic conditions: roles for p53 and HIF-1
Katarzyna B Leszczynska, Eva-Leonne Göttgens, Deborah Biasoli, et al.
Scientific Reports
|
December 15, 2020
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies
Adam Byron, Stephan Bernhardt, Bérèngere Ouine, et al.
Cancers
|
May 28, 2022
Disentangling ERBB Signaling in Breast Cancer Subtypes-A Model-Based Analysis
Svenja Kemmer, Mireia Berdiel-Acer, Eileen Reinz, et al.
Molecular Oncology
|
July 14, 2018
TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer
Christian Breunig, Nese Erdem, Alexander Bott, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Microarrays (Basel, Switzerland)
|
September 8, 2016
Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery
Astrid Wachter, Stephan Bernhardt, Tim Beissbarth, et al.
Expert Review of Proteomics
|
November 18, 2014
Subtyping of breast cancer using reverse phase protein arrays
Johanna Sonntag, Kerstin Schlüter, Stephan Bernhardt, et al.
Future Oncology (London, England)
|
March 16, 2021
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry
Arne Strauss, Marianne Schmid, Michael Rink, et al.
Future Oncology (London, England)
|
October 6, 2020
Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry
Martin Boegemann, Katrin Schlack, Michael Rink, et al.
Journal of Proteome Research
|
January 5, 2019
Functional Proteomics of Breast Cancer Metabolism Identifies GLUL as Responder during Hypoxic Adaptation
Stephan Bernhardt, Christian Tönsing, Devina Mitra, et al.
International Journal of Molecular Sciences
|
November 1, 2014
Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization
Matthias Bache, Stephan Bernhardt, Sarina Passin, et al.
Scientific Reports
|
February 16, 2016
Mechanisms and consequences of ATMIN repression in hypoxic conditions: roles for p53 and HIF-1
Katarzyna B Leszczynska, Eva-Leonne Göttgens, Deborah Biasoli, et al.
Scientific Reports
|
December 15, 2020
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies
Adam Byron, Stephan Bernhardt, Bérèngere Ouine, et al.
Cancers
|
May 28, 2022
Disentangling ERBB Signaling in Breast Cancer Subtypes-A Model-Based Analysis
Svenja Kemmer, Mireia Berdiel-Acer, Eileen Reinz, et al.
Molecular Oncology
|
July 14, 2018
TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer
Christian Breunig, Nese Erdem, Alexander Bott, et al.
Page
of 2